China Medical System:First Ruxolitinib Cream’s Prescriptions for Vitiligo Issued in the Greater Bay Area
SHENZHEN, CHINA – China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 18 October, the first batch of prescriptions of ruxolitinib phosphate cream (the “ruxolitinib cream” or the “Product”) for qualified vitiligo patients were issued in the Greater Bay… Read More